Webinars & e-learning courses All webinars

Clinical Feline Oncology

Clinical Feline Oncology
Clinical Feline Oncology

This webinar covers the general approach to the feline oncology patient as well as dealing with specifics on lymphoma and soft tissue sarcoma.

Language: English

In case you have missed this webinar, you have the opportunity to watch a recorded version here.

This webinar qualifies for one (1) hour of continuing education.

Booking information

Duration: 1:01 h
from 1
54.90 US$
(incl. tax)

You might also be interested in

veterinary-gb0489bee6_1920300x200.jpg
Penny Thomas
0:51 h

Supportive Care for Cancer Patients for Nurses

How to provide the best nursing care for patients with cancer 
ICC image small.jpg
Sue Jaensch
0:50 h

Advanced diagnostics in canine and feline lymphoma.

So you have a diagnosis of lymphoma in your small animal patient. What next?  Classification of lymphoma is increasingly important for both prognostic and therapeutic decision making. This webinar will discuss diagnostic options to optimise the diagnostic process in your patient.  Modalities discussed will include immunocytochemistry, immunohistochemistry, flow cytometry and PARR. 
staging-the-oncology-patient.png
Laura Brockley
0:57 h

Staging the Oncology Patient

Staging is one of the most important components of oncology case management. It involves determining the extent of local disease along with the presence or absence of regional or distant metastasis. The results of staging are used to give more accurate and informed treatment options along with prognostic information for each oncology patient. Some of the biggest challenges in staging is to consider how much staging is required for each case, which are the most appropriate tests, and if the results of these tests will impact treatment options and prognosis. I will discuss this information in a case-based and evidence-based approach, focusing on some of the more common cancers including canine mast cell tumours, lymphoma, oral tumours and apocrine gland anal sac adenocarcinomas.